Delivery Order SPE2DX22D0020-SPE2D825F37EC
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $27,768.48 to AmerisourceBergen Drug Corp on July 9, 2025, with an ultimate completion date of July 10, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The work will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a $561,251.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for completion by July 29, 2025. This non-competitive, non-set-aside delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is being performed at the awardee's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $386,479.07 to AmerisourceBergen Drug Corp on July 21, 2025, for pharmaceutical and medical supply distribution. This firm fixed-price, non-set-aside contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $873,379.40 to AmerisourceBergen Drug Corp on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999,999,999.00 ceiling and extends through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a $47,827.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-set-aside competitive award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The delivery order represents a child contract fulfilling pharmaceutical and medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,307.41 to AmerisourceBergen Drug Corp on July 14, 2025, with completion expected by July 15, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a $109,904.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, with completion scheduled for July 14, 2025. This non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the contractor's corporate office location...
- The Defense Logistics Agency Medical Supply Chain awarded a $22,129.63 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a $317,823.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 16, 2025, with completion scheduled for June 17, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D825F37ECDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $935,623.49 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a child award under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a critical pharmaceutical distributor for federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in fulfilling federal medical supply requirements through multiple competitive awards. The company supplies comprehensive pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems. This delivery order falls within the broader context of the DLA Troop Support Pharmaceutical Prime Vendor Global Program, which is structured to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with flexible and comprehensive medical supply capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $935.6k | 7/26/25 |